Biotech dealmaking is increasingly defined by a clear strategic shift: Pharmaceutical companies are prioritizing de-risked, late-stage assets with human clinical validation rather than speculative ...

There are an estimated 35,000 people in Michigan with Parkinson’s – a progressive neurological disorder. Kirk Gibson is fighting for them all.

Bridging the divide between Parkinson scientists and the Parkinson community At the heart of our work is connection: ...

Who is that guy? The one from Elf… what’s his name,” Phil Parkinson asks Wrexham’s long-serving head of media Colin Henrys.

Even though aging is the largest risk factor for Parkinson’s disease, the majority of research aimed at taming the incurable neurodegenerative motor disease has largely left aging out of the mix.  A ...

Outlines clinical and growth catalysts for ONP-002 in concussion and mild traumatic brain injury (mTBI) Fully prepared to initiate near-term ...

Strengthens Global IP Portfolio for PrimeC Through 2042 CAMBRIDGE, Mass., Feb. 9, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology ...

There’s an instant payoff on that Parkinson’s Law analogy; more oversight, aka more people, will be needed for AI coding and ...

Add Yahoo as a preferred source to see more of our stories on Google. Weekly activity sessions for people with Parkinson's disease have been set up in Wolverhampton. City of Wolverhampton Council is ...

Newly-discovered markers in peoples’ blood can help identify the earliest signs of Parkinson’s disease years before symptoms start, Swedish researchers said Thursday. “By the time the motor symptoms ...

Australia Day is just days away, and organisers across the Northern Territory have laid out their plans ahead of the national day. Read our list of where and how you can get involved in this year’s ...